Related Experiment Video
Updated: May 7, 2026
12:03
Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
27.9K
Postoperative Myocardial Infarction Due to Coronary Embolization of Valve Tissue After Surgical Mitral Valve
Hasan Hadzalic1, Selma Hasific2, Luca Oechslin1
1Heart Clinic Hirslanden, Zurich, Switzerland.
JACC. Case Reports
|March 29, 2024
Insights
A 61-year-old man with Barlow's disease experienced heart attack and cardiac arrest shortly after minimally invasive mitral valve surgery. This was caused by coronary artery occlusion from native mitral valve tissue.
Area of Science:
- Cardiovascular Surgery
- Cardiology
- Cardiac Pathology
Background:
- Barlow's disease, a degenerative mitral valve disorder, can necessitate surgical intervention.
- Minimally invasive mitral valve surgery offers potential benefits but carries risks.
- Coronary artery complications post-cardiac surgery require careful consideration.
Observation:
- A 61-year-old male patient with pre-existing Barlow's disease underwent minimally invasive mitral valve surgery.
- The patient experienced immediate postoperative myocardial infarction and cardiac arrest within one hour.
- The critical event was linked to coronary artery occlusion.
Findings:
- Native mitral valve tissue was identified as the cause of coronary artery occlusion.
- This occlusion occurred in the immediate postoperative period following mitral valve surgery.
- The patient suffered a myocardial infarction and cardiac arrest due to the obstruction.
Implications:
- This case highlights a rare but critical complication of mitral valve surgery.
- Native valve tissue obstruction of coronary arteries is a potential cause of acute cardiac events post-surgery.
- Awareness and diagnostic vigilance are crucial for managing such adverse events in cardiac surgery patients.
Abstract:
We present the case of a 61-year-old man with known Morbus Barlow disease, who presented with postoperative myocardial infarction and cardiac arrest within 1 hour after minimally invasive mitral valve surgery owing to coronary artery occlusion by native mitral valve tissue.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...